Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

Université de Montréal

$123,823.00

A new method for real-time monitoring of acute inflammation with ultrasound

EF 2008-09

Résumé
In Canada, 47000 cardiac surgeries are performed annually and a cardiopulmonary bypass (CPB) is done in a large portion of them. However, CPB induces a systemic inflammatory response that triggers pathological events affecting multiple organs and, in approximately 15% of severe cases, results in poor outcomes or death. With aging, mortality is increasing mostly through reduced ability to treat inflammatory consequences of cardiac surgery. Clinically, there is currently no indication to preventively treat CPB patients with anti-inflammatory drugs, mainly because of the absence of clearly documented benefits using randomized clinical trials. Although not of common practice, inflammatory markers are measured in some research studies during CPB but results are obtained hours or days after the operation. They are used to document inflammation but have no impact peri-op or post-op. Continuous monitoring of inflammation would be essential to evaluate the effect of any form of anti-inflammatory therapy used during cardiac surgery or to pre-select patients for post-op therapy. Red blood cell (RBC) aggregation is a strong marker of inflammation and has the unique advantage of offering continuous monitoring capability through ultrasound imaging. This grant aims to validate a new quantitative method based on ultrasound radio-frequency spectral analysis to measure the time-varying clustering of RBCs during acute inflammation, and to make comparison with known markers of inflammation. Once validated, the clinical impact of this method would be tremendous. For instance, the next step is to design a prospective clinical trial where the inflammatory reaction of patients undergoing CPB would be quantified in real-time and a decision made during the procedure to use or not a preventive anti-inflammatory drug therapy. This approach may help to select high risk patients that would then benefit in receiving anti-inflammatory agents or other experimental drugs, and monitor their response to treatment. The proposed method aimed to be implemented in a portable medical instrument.
Programme
Idea to Innovation
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
372485-2008
Name nom
Cloutier, Guy
Department département
Radiologie, radio-oncologie et médecine nucléaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
123823
Program id
I2IPJ
Program nane en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1 & 2
Nb partie
2
Application title
A new method for real-time monitoring of acute inflammation with ultrasound
Keyword
NA
Application summary
In Canada, 47000 cardiac surgeries are performed annually and a cardiopulmonary bypass (CPB) is done in a large portion of them. However, CPB induces a systemic inflammatory response that triggers pathological events affecting multiple organs and, in approximately 15% of severe cases, results in poor outcomes or death. With aging, mortality is increasing mostly through reduced ability to treat inflammatory consequences of cardiac surgery. Clinically, there is currently no indication to preventively treat CPB patients with anti-inflammatory drugs, mainly because of the absence of clearly documented benefits using randomized clinical trials. Although not of common practice, inflammatory markers are measured in some research studies during CPB but results are obtained hours or days after the operation. They are used to document inflammation but have no impact peri-op or post-op. Continuous monitoring of inflammation would be essential to evaluate the effect of any form of anti-inflammatory therapy used during cardiac surgery or to pre-select patients for post-op therapy. Red blood cell (RBC) aggregation is a strong marker of inflammation and has the unique advantage of offering continuous monitoring capability through ultrasound imaging. This grant aims to validate a new quantitative method based on ultrasound radio-frequency spectral analysis to measure the time-varying clustering of RBCs during acute inflammation, and to make comparison with known markers of inflammation. Once validated, the clinical impact of this method would be tremendous. For instance, the next step is to design a prospective clinical trial where the inflammatory reaction of patients undergoing CPB would be quantified in real-time and a decision made during the procedure to use or not a preventive anti-inflammatory drug therapy. This approach may help to select high risk patients that would then benefit in receiving anti-inflammatory agents or other experimental drugs, and monitor their response to treatment. The proposed method aimed to be implemented in a portable medical instrument.